EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Preoperative Cer(d18:1/24:0) Shows Promise as a Candidate Predictor of Plasma Lipid Phenotypes Following Roux‐en‐Y Gastric Bypass in Women: An Exploratory Analysis of the SURMetaGIT Study

Gabriela de O Lemos iD, Raquel S M Torrinhas iD, Jéssica M Volejnik Pino iD, Philip C Calder iD, Steven B Heymsfield iD, Natasha M Machado iD, Dan L Waitzberg iD

Journal of Obesity · 2026-01 · 2026 (1)

DOI: 10.1155/jobe/2335829 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Obesity, online erschienen am 12.08.2026. Verfasst von Gabriela de O Lemos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Gastroenterologia, Universidade de São Paulo, São Paulo, São Paulo, Brazil, usp.br. Hauptthemen laut MEDLINE: Ceramides, Diabetes Mellitus, Type 2, Gastric Bypass, Lipids. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Roux‐en‐Y gastric bypass (RYGB) surgery is known to improve lipid profiles in individuals with obesity, but the degree of improvement varies. Emerging evidence suggests a role for sphingolipids in modulating cholesterol metabolism. This study investigated the relationship between plasma sphingolipid changes and cholesterol improvements in women with obesity and Type 2 diabetes mellitus (T2DM) following RYGB. Patients from the SURMetaGIT study were evaluated before and 3 months after surgery. Biochemical and sphingolipid analyses, anthropometric measures, and body composition were assessed. A nonhierarchical cluster analysis assessed distinct phenotypes in response to cholesterol after surgery. The p value from multiple comparison tests was adjusted using the false discovery rate (FDR) method. A metabolite fold change [log 2 (postoperative mean/preoperative mean)] of 1.2 and an adjusted p value < 5% were considered statistically significant. A linear regression model was used to investigate the relationship between sphingolipids and cholesterol levels. Finally, a binary logistic regression model was developed to identify the predictive value of specific discriminative sphingolipids in the lipid improvement after RYGB. Distinct sphingolipid remodeling patterns were observed, with specific sphingolipids, including Cer(d18:1/24:0), SM(d18:1/22:0), and SM(d18:1/24:0), presenting a strong positive correlation with cholesterol levels, independent of weight loss and T2DM remission. The binary logistic regression showed preoperative Cer(d18:1/24:0) could be the strongest candidate predictor of plasma lipid improvement after surgery (accuracy of 78%; AUC 0.87). These findings suggest that specific sphingolipids, notably preoperative Cer(d18:1/24:0), seemed to have a potential role in predicting cholesterol improvement after RYGB. External validation in independent cohorts is warranted before clinical applicability can be established. Trial Registration: ClinicalTrials.gov identifier: NCT01251016

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesDiabetes Mellitus, Type 2Gastric BypassLipidsObesity, MorbidAdultFemaleHumansMiddle AgedBiomarkersCholesterolPhenotypePreoperative PeriodWeight Loss

Stichwörter der Autor:innen

Roux-en-Y gastric bypassbariatric surgerycholesterolmetabolomicssphingolipids

Substanzen

BiomarkersCeramidesCholesterolLipids

Autor:innen und Institutionen

  • Departamento de Gastroenterologia, Universidade de São Paulo, São Paulo, São Paulo, Brazil, usp.br.
  • Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil, unifesp.br.
  • School of Human Development and Health, University of Southampton, Southampton, UK, southampton.ac.uk.
  • NIHR Southampton Biomedical Research Centre, Southampton, UK.
  • Pennington Biomedical Research Foundation, Baton Rouge, Louisiana, USA.

ORCID-Profile: Gabriela de O Lemos, Raquel S M Torrinhas, Jéssica M Volejnik Pino, Philip C Calder, Steven B Heymsfield, Natasha M Machado, Dan L Waitzberg

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Lemos, G. O., Torrinhas, R. S. M., Pino, J. M. V., Calder, P. C., Heymsfield, S. B., Machado, N. M., & Waitzberg, D. L. (2026). Preoperative Cer(d18:1/24:0) Shows Promise as a Candidate Predictor of Plasma Lipid Phenotypes Following Roux‐en‐Y Gastric Bypass in Women: An Exploratory Analysis of the SURMetaGIT Study. Journal of Obesity, 2026(1). https://doi.org/10.1155/jobe/2335829

Vancouver

Lemos GO, Torrinhas RSM, Pino JMV, Calder PC, Heymsfield SB, Machado NM, et al. Preoperative Cer(d18:1/24:0) Shows Promise as a Candidate Predictor of Plasma Lipid Phenotypes Following Roux‐en‐Y Gastric Bypass in Women: An Exploratory Analysis of the SURMetaGIT Study. Journal of Obesity. 2026;2026(1). doi:10.1155/jobe/2335829

BibTeX
@article{Lemos2026,
  author = {Lemos, Gabriela de O and Torrinhas, Raquel S M and Pino, Jéssica M Volejnik and Calder, Philip C and Heymsfield, Steven B and Machado, Natasha M and Waitzberg, Dan L},
  title = {Preoperative Cer(d18:1/24:0) Shows Promise as a Candidate Predictor of Plasma Lipid Phenotypes Following Roux‐en‐Y Gastric Bypass in Women: An Exploratory Analysis of the SURMetaGIT Study},
  journal = {Journal of Obesity},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jobe/2335829}
}
Kostenlos starten →